Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs

被引:0
|
作者
Vincent Montoya
Anita Y. M. Howe
Weiyan Y. Dong
Winnie Dong
Chanson J. Brumme
Andrea D. Olmstead
Kanna Hayashi
P. Richard Harrigan
Jeffrey B. Joy
机构
[1] British Columbia Centre for Excellence in HIV/AIDS,Department of Medicine
[2] British Columbia Centre for Disease Control,Faculty of Health Sciences
[3] University of British Columbia,Bioinformatics Program
[4] Simon Fraser University,undefined
[5] British Columbia Centre on Substance Use,undefined
[6] University of British Columbia,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Most individuals chronically infected with hepatitis C virus (HCV) are asymptomatic during the initial stages of infection and therefore the precise timing of infection is often unknown. Retrospective estimation of infection duration would improve existing surveillance data and help guide treatment. While intra-host viral diversity quantifications such as Shannon entropy have previously been utilized for estimating duration of infection, these studies characterize the viral population from only a relatively short segment of the HCV genome. In this study intra-host diversities were examined across the HCV genome in order to identify the region most reflective of time and the degree to which these estimates are influenced by high-risk activities including those associated with HCV acquisition. Shannon diversities were calculated for all regions of HCV from 78 longitudinally sampled individuals with known seroconversion timeframes. While the region of the HCV genome most accurately reflecting time resided within the NS3 gene, the gene region with the highest capacity to differentiate acute from chronic infections was identified within the NS5b region. Multivariate models predicting duration of infection from viral diversity significantly improved upon incorporation of variables associated with recent public, unsupervised drug use. These results could assist the development of strategic population treatment guidelines for high-risk individuals infected with HCV and offer insights into variables associated with a likelihood of transmission.
引用
收藏
相关论文
共 50 条
  • [1] Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs
    Montoya, Vincent
    Howe, Anita Y. M.
    Dong, Weiyan Y.
    Dong, Winnie
    Brumme, Chanson J.
    Olmstead, Andrea D.
    Hayashi, Kanna
    Harrigan, P. Richard
    Joy, Jeffrey B.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [2] Hepatitis C Virus Vaccines Among People Who Inject Drugs
    Cox, Andrea L.
    Thomas, David L.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 : S46 - S50
  • [3] Agent, Host, and Environment: Hepatitis C Virus in People Who Inject Drugs
    Hagan, Holly
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (12): : 1819 - 1821
  • [4] Hepatitis C virus network dynamics among people who inject drugs in Vancouver, Canada
    Jacka, Brendan
    Poon, Art
    Applegate, Tanya L.
    Krajden, Mel
    Olmstead, Andrea
    Harrigan, Richard
    Marshall, Brandon D.
    DeBeck, Kora
    Milloy, M-J
    Lamoury, Francois
    Pybus, Oliver
    Lima, Viviane
    Magiorkinis, Gkikas
    Montoya, Vincent
    Montaner, Julio
    Joy, Jeffrey
    Dore, Gregory J.
    Kerr, Thomas
    Wood, Evan
    Grebely, Jason
    [J]. HEPATOLOGY, 2014, 60 : 907A - 908A
  • [5] Hepatitis C virus risk among young people who inject drugs
    Mateu-Gelabert, Pedro
    Sabounchi, Nasim S.
    Guarino, Honoria
    Ciervo, Courtney
    Joseph, Kellie
    Eckhardt, Benjamin J.
    Fong, Chunki
    Kapadia, Shashi N.
    Huang, Terry T. K.
    [J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [6] Intra-host evolutionary dynamics of hepatitis C virus E2 in treated patients
    Alfonso, V
    Mbayed, VA
    Sookoian, S
    Campos, RH
    [J]. JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 2781 - 2786
  • [7] Recommendations for the management of hepatitis C virus infection among people who inject drugs
    Grebely, Jason
    Robaeys, Geert
    Bruggmann, Philip
    Aghemo, Alessio
    Backmund, Markus
    Bruneau, Julie
    Byrne, Jude
    Dalgard, Olav
    Feld, Jordan J.
    Hellard, Margaret
    Hickman, Matthew
    Kautz, Achim
    Litwin, Alain
    Lloyd, Andrew R.
    Mauss, Stefan
    Prins, Maria
    Swan, Tracy
    Schaefer, Martin
    Taylor, Lynn E.
    Dore, Gregory J.
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (10) : 1028 - 1038
  • [8] Mitigating the burden of hepatitis C virus among people who inject drugs in Belgium
    Mathei, Catharina
    Bourgeois, Stefan
    Blach, Sarah
    Brixko, Christian
    Mulkay, Jean-Pierre
    Razavi, Homie
    Robaeys, Geert
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2016, 79 (02): : 227 - 232
  • [9] Hepatitis C Virus Dynamic Transmission Models Among People Who Inject Drugs
    Woyesa, Shiferaw Bekele
    Amente, Kellemuwa Desalegn
    [J]. INFECTION AND DRUG RESISTANCE, 2023, 16 : 1061 - 1068
  • [10] Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
    Robaeys, Geert
    Grebely, Jason
    Mauss, Stefan
    Bruggmann, Philip
    Moussalli, Joseph
    De Gottardi, Andrea
    Swan, Tracy
    Arain, Amber
    Kautz, Achim
    Stoever, Heino
    Wedemeyer, Heiner
    Schaefer, Martin
    Taylor, Lynn
    Backmund, Markus
    Dalgard, Olav
    Prins, Maria
    Dore, Gregory J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 : S129 - S137